Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Journal of Affective Disorders|June 12, 2024
Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study reportAbraham Nunes, Barbara Pavlova, Jasmyn E A Cunningham, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 28, 2024
Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive DisorderNatalie C W Ho, Richard A I Bethlehem, Jakob Seidlitz, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|January 15, 2022
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression StudyPrabhjot Dhami, Lena C Quilty, Benjamin Schwartzmann, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 18, 2025
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeurAnees Bahji, Elisa Brietzke, Noah C A Cooke, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 24, 2025
Standardized EEG for multi-site biomarker-informed trials: Implementation in the Canadian Biomarker Integration Network in DepressionBenjamin Schwartzmann, Prabhjot Dhami, Raaj Chatterjee, et al.
Journal of Affective Disorders|November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyAnusha Baskaran, Faranak Farzan, Roumen Milev, et al.
The Journal of Clinical Psychiatry|May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant TreatmentRaoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Translational Psychiatry|September 11, 2021
Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 reportAntoine Yrondi, Laura M Fiori, Nikita Nogovitsyn, et al.
Scientific Reports|August 9, 2017
Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depressionFaranak Farzan, Sravya Atluri, Matthew Frehlich, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive DisorderJoshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Pageof 18